Beta-blockers for anxiety: systemic overmedicalization obscures stress as a socio-economic symptom, not just a biochemical glitch
Original framing: “How do beta blocker heart drugs actually work for anxiety?” — The Conversation - Global
Marginalized communities often experience anxiety as a compounded effect of systemic racism, ableism, and classism—such as Black Americans’ heightened vigilance due to police violence or disabled people’s stress from inaccessible environments. Indigenous activists frame anxiety as a symptom of land dispossession (e.g., Standing Rock water protectors’ stress from state violence), while migrant workers report anxiety from employer coercion. These voices are routinely excluded from clinical trials, leading to biased treatment protocols.
The beta-blocker narrative exemplifies how biomedical reductionism obscures anxiety’s socio-economic and historical production, serving pharmaceutical markets while depoliticizing distress.
Historically, anxiety has been a byproduct of capitalist extraction—from Taylorism to gig work—yet modern medicine frames it as a neurotransmitter glitch, erasing the role of precarity, racism, and climate collapse. Indigenous and marginalized voices reveal anxiety as a relational and ecological rupture, not an isolated flaw, while trickster wisdom exposes the absurdity of treating symptoms of systemic dysfunction with pills. Future solutions must invert this logic: universal basic services, decolonized healing, and algorithmic accountability could reduce anxiety by addressing its roots, not just its branches. The choice is not between 'natural' and 'pharmaceutical' remedies, but between systems that manufacture distress and those that heal it.